RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+7.63%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$2.68B
AUM Growth
+$2.68B
(+13%)
Cap. Flow
+$68.9M
Cap. Flow
% of AUM
2.57%
Top 10 Holdings %
Top 10 Hldgs %
48.88%
Holding
71
New
8
Increased
19
Reduced
13
Closed
11
Top Buys
| 1 |
Roivant Sciences
ROIV
|
$95.5M |
| 2 |
NCR Voyix
VYX
|
$60.7M |
| 3 |
Liberty Global Class A
LBTYA
|
$52.9M |
| 4 |
QuidelOrtho
QDEL
|
$50.4M |
| 5 |
Stratasys
SSYS
|
$47.7M |
Top Sells
| 1 |
Cameco
CCJ
|
$100M |
| 2 |
Hertz
HTZ
|
$63.3M |
| 3 |
NRG Energy
NRG
|
$50.8M |
| 4 |
HOLI
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
|
$38.5M |
| 5 |
Fluor
FLR
|
$34.1M |
Sector Composition
| 1 | Healthcare | 49.45% |
| 2 | Financials | 9.73% |
| 3 | Technology | 8.83% |
| 4 | Energy | 7.21% |
| 5 | Materials | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Roivant Sciences
ROIV
$8.15B
| $213M | 4.43% | 19,000,000 +8,500,000 | +81% | +$95.5M |
|
2
Teva Pharmaceuticals
TEVA
$21.1B
| $190M | 3.95% | 18,226,601 -773,399 | -4% | -$8.07M |
|
3
Viatris
VTRS
$12.3B
| $190M | 3.95% | 17,567,892 +4,317,892 | +33% | +$46.8M |
|
4
Golar LNG
GLNG
$4.48B
| $150M | 3.1% | 6,506,757 | – | – |
|
5
BGC Group
BGC
$4.65B
| $144M | 3% | 20,000,000 | – | – |
|
6
Mr. Cooper
COOP
$12.1B
| $116M | 2.41% | 1,785,795 -179,378 | -9% | -$11.7M |
|
7
Collegium Pharmaceutical
COLL
$1.22B
| $84.9M | 1.76% | 2,758,253 -416,747 | -13% | -$12.8M |
|
8
ReNew
RNW
$2.76B
| $79.8M | 1.66% | 10,420,000 +522,574 | +5% | +$4M |
|
|
9
QuidelOrtho
QDEL
$1.95B
| $72.2M | 1.5% | 980,063 +683,637 | +231% | +$50.4M |
|
|
PTVE
10
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $69.1M | 1.43% | 5,039,766 +39,766 | +0.8% | +$545K |
|
11
ANI Pharmaceuticals
ANIP
$2.03B
| $62M | 1.29% | 1,125,000 +277,989 | +33% | +$15.3M |
|
|
12
NCR Voyix
VYX
$1.82B
| $60.7M | 1.26% | +3,591,228 | New | +$60.7M |
|
|
13
Stratasys
SSYS
$906M
| $60.7M | 1.26% | 4,250,000 +3,339,367 | +367% | +$47.7M |
|
|
14
Fluor
FLR
$6.63B
| $59.2M | 1.23% | 1,510,172 -869,485 | -37% | -$34.1M |
|
15
Constellium
CSTM
$2.02B
| $58.4M | 1.21% | 2,924,438 +970,164 | +50% | +$19.4M |
|
16
Adeia
ADEA
$1.64B
| $57.5M | 1.19% | 4,640,009 | – | – |
|
17
AAR Corp
AIR
$2.72B
| $55.9M | 1.16% | 895,904 -332,518 | -27% | -$20.7M |
|
18
Dole
DOLE
$1.4B
| $55.7M | 1.16% | 4,530,940 +788,788 | +21% | +$9.69M |
|
|
19
Liberty Global Class A
LBTYA
$4B
| $52.9M | 1.1% | +2,979,328 | New | +$52.9M |
|
20
Koppers
KOP
$571M
| $51.6M | 1.07% | 1,007,341 -131,251 | -12% | -$6.72M |
|
21
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $51M | 1.06% | 2,907,501 -169,948 | -6% | -$2.98M |
|
22
Orthofix Medical
OFIX
$592M
| $49.4M | 1.03% | 3,665,000 +230,335 | +7% | +$3.1M |
|
23
Amneal Pharmaceuticals
AMRX
$3B
| $48.6M | 1.01% | 8,000,000 +3,975,500 | +99% | +$24.1M |
|
24
Heron Therapeutics
HRTX
$207M
| $45.4M | 0.94% | 26,713,503 | – | – |
|
25
Par Pacific Holdings
PARR
$1.76B
| $43.6M | 0.91% | 1,199,749 -772,432 | -39% | -$28.1M |
|